Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared a post on LinkedIn:
“New GI25 abstracts now released!
Neoadjuvant immunotherapy continues to impress! Building upon the paradigm shift of immunotherapy to earlier settings – CURES
– NEST
– UNICORN
– NICHE
These trials~80 treated. SAFE.
Time for a phase-2/3.”
